Results of Myeloablative Allogenic Stem Cell Transplant (SCT) for Severe Sickle Cell Disease in France

Reviewer: Julie Draznin Maltzman, MD
OncoLink
Ultima Vez Modificado: 8 de diciembre del 2002

Translation for this article does not exist